[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368156-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368156-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","rrferv-stabilizes-tead1-expression-to-mediate-nasopharyngeal-cancer-radiation-resistance-rendering-tumor-cells-vulnerable-to-ferroptosis","RRFERV stabilizes TEAD1 expression to mediate nasopharyngeal cancer radiation resistance rendering tumor cells vulnerable to ferroptosis","","RRFERV is investigated as a long noncoding RNA driving malignant progression in nasopharyngeal carcinoma by shaping radiation response. RNA sequencing and bioinformatics identify RRFERV, and in vitro/in vivo experiments with Western blot, qRT-PCR, RIP, and flow cytometry quantify its activity. Results show elevated RRFERV in NPC tissues and radiation-resistant cells, correlating with poor outcomes and stabilizing TEAD1 via microRNA-615-5p and microRNA-1293. The RRFERV–TEAD1 axis enhances radiotherapy resistance through ACSL4/TFRC-mediated lipid peroxidation and places cells in an oxidative stress equilibrium that sensitizes ferroptosis inducers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/rrferv-stabilizes-tead1-expression-to-mediate-nasopharyngeal-cancer-radiation-resistance-rendering-tumor-cells-vulnerable-to-ferroptosis/368156/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/rrferv-stabilizes-tead1-expression-to-mediate-nasopharyngeal-cancer-radiation-resistance-rendering-tumor-cells-vulnerable-to-ferroptosis/368156.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does RRFERV play in nasopharyngeal carcinoma radiation resistance?","Question",{"text":63,"@type":64},"RRFERV is highly expressed in NPC tissues and radiation-resistant cells, and its high expression is associated with poor clinical outcomes. It stabilizes TEAD1 through competitive binding with microRNA-615-5p and microRNA-1293, supporting malignant progression and radiotherapy resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was RRFERV expression and function measured in the study?",{"text":68,"@type":64},"RNA sequencing and bioinformatic analysis identified RRFERV’s potential function. Expression and related mechanisms were assessed using Western blotting, qRT-PCR, RIP assays, and flow cytometry.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are radiation-resistant NPC cells more sensitive to ferroptosis inducers?",{"text":72,"@type":64},"The study reports that radiation-resistant cells exist in a fragile oxidative stress equilibrium. This state makes them more sensitive to ferroptosis inducers, enabling ferroptosis to effectively kill cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368156,1790369809,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","’Experimental Research  \nRRFERV stabilizes TEAD1 expression to mediatenasopharyngeal cancer radiation resistance rendering tumor cells vulnerable to ferroptosis  \nQingqing Xu, MDa,b,c , Xin Wen, MDd , Chenglong Huang, MDa,b,c , Zaishan Lin, MDa,b,c , Zhen Xu, MDa,b,c , Ciming Sun, MDa,b,c , Li Li, PhDa,b,c , Suixian Zhang, MDa,b,c , Shuanghong Song, MDa,b,c , Jiahao Lou, MDa,b,c , Zan Hou, MDa,b,c , Yuanyuan Chen, MDa,b,c,*, Xuan Li, PhDa,b,c,*, Lei Chen, MDa,b,c,*  \nBackground: Long noncoding RNAs (lncRNAs) regulate various essential biological processes, including cell proliferation, differentiation, apoptosis, migration, and invasion. However, in nasopharyngeal carcinoma (NPC), the clinical signiﬁcance and mechanisms of lncRNAs in malignant progression are unknown.  \nMethods: RNA sequencing and bioinformatic analysis were used to determine the potential function of RRFERV (radiation-resistant but ferroptosis-vulnerable), and its biological effects were investigated using in vitro and in vivo experiments. Western blotting, quantitative real-time reverse transcription PCR, RNA immunoprecipitation (RIP) assays, and ﬂow cytometry detected RRFERV expression. Ferroptosis and lipid peroxidation were added to evaluate the relationship between it and radiotherapy resistance. Results: LncRNA–RRFERV was both highly expressed in NPC tissues and radiation-resistant cells. RRFERV is associated with poor clinical outcomes of NPC patients and stabilizes TEAD1 by competitive binding with microRNA-615-5p and microRNA-1293 . RRFERV–TEAD1 signaling axis leads to malignant progression and radiotherapy resistance of NPC. Furthermore, we observed that NPC radiotherapy-resistance cells exist in a fragile oxidative stress equilibrium, which makes them more sensitive to ferroptosis inducers. Surprisingly, we found that RRFERV–TEAD1 signaling axis also plays a key role in mediating the lipid peroxidation levels of NPC radiotherapy-resistance cells through transcriptional activation of ACSL4/TFRC.  \nConclusions: RRFERV serves as an independent prognostic factor in NPC. During the malignant progression of NPC caused by high expression of RRFERV, ferroptosis can be induced to effectively kill cancer cells and reverse the radiotherapy resistance of NPC cells, suggesting a potential treatment approach for recurrent and refractory NPC.  \nKeywords: ferroptosis, nasopharyngeal carcinoma, radiation resistance, RRFERV, TEAD1  \nIntroduction  \nNasopharyngeal carcinoma (NPC) is a unique head and neck cancer that has a distinct geographical distribution and different biological characteristics from other head and neck tumors[1] . It is endemic in Southeast Asia and Southern China, where it accounted for over 70% of the estimated 133 354 worldwide cases in 2020[2] . Approximately 95% of cases in endemic areas  \nare non-keratinizing NPC[3], which is radiosensitive; therefore, radiotherapy (RT) is the primary treatment modality for non metastatic NPC. With advances in contemporary cancer management, including intensity-modulated radiotherapy and combined chemotherapy, the survival rate of patients with nonmetastatic NPC has increased greatly; however, after standard treatment, around 30% of patients experience metastasis and recur  \naState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China, bDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China, cUnited Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co,  \nGuangzhou, China and dDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China Qingqing Xu, Xin Wen, Chenglong Huang, Zaishan Lin, and Zhen Xu contributed equally to this work.  \nSponsorships or competing interests that may be relevant ","cbCaiswkcpT7F6XT","https://ap.wps.com/l/cbCaiswkcpT7F6XT","pdf",1878082,17,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Epidemiology and treatment context\n## Clinical need for new combinations","[{\"question\":\"What role does RRFERV play in nasopharyngeal carcinoma radiation resistance?\",\"answer\":\"RRFERV is highly expressed in NPC tissues and radiation-resistant cells, and its high expression is associated with poor clinical outcomes. It stabilizes TEAD1 through competitive binding with microRNA-615-5p and microRNA-1293, supporting malignant progression and radiotherapy resistance.\"},{\"question\":\"How was RRFERV expression and function measured in the study?\",\"answer\":\"RNA sequencing and bioinformatic analysis identified RRFERV’s potential function. Expression and related mechanisms were assessed using Western blotting, qRT-PCR, RIP assays, and flow cytometry.\"},{\"question\":\"Why are radiation-resistant NPC cells more sensitive to ferroptosis inducers?\",\"answer\":\"The study reports that radiation-resistant cells exist in a fragile oxidative stress equilibrium. This state makes them more sensitive to ferroptosis inducers, enabling ferroptosis to effectively kill cancer cells.\"}]","RRFERV stabilizes TEAD1 expression to mediate nasopharyngeal cancer radiation resistance rendering tumor cells vulnerable to ferroptosis | PDF",1790175314,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca45bec80d88073d47fee2106f9c9143.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81842ac2b12c20f0b016f01ca6d4ef19.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/652cb78b625596f326539b6ede9c6d14.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f93e7b9efb5d114fda2fd8bf85f858e2.webp",980,1306]